Bioabsorbable Intracoronary Matrix for Prevention of Ventricular Remodeling After Myocardial Infarction.
Identifieur interne : 002263 ( PubMed/Checkpoint ); précédent : 002262; suivant : 002264Bioabsorbable Intracoronary Matrix for Prevention of Ventricular Remodeling After Myocardial Infarction.
Auteurs : Sunil V. Rao [États-Unis] ; Uwe Zeymer [Allemagne] ; Pamela S. Douglas [États-Unis] ; Hussein Al-Khalidi [États-Unis] ; Jennifer A. White [États-Unis] ; Jingyu Liu [États-Unis] ; Howard Levy [États-Unis] ; Victor Guetta [Israël] ; C Michael Gibson [États-Unis] ; Jean-Francois Tanguay [Canada] ; Paul Vermeersch [Belgique] ; Jérôme Roncalli [France] ; Jaroslaw D. Kasprzak [Pologne] ; Timothy D. Henry [États-Unis] ; Norbert Frey [Allemagne] ; Oscar Kracoff [Israël] ; Jay H. Traverse [États-Unis] ; Derek P. Chew [Australie] ; Jose Lopez-Sendon [Espagne] ; Reinilde Heyrman [États-Unis] ; Mitchell W. Krucoff [États-Unis]Source :
- Journal of the American College of Cardiology [ 1558-3597 ] ; 2016.
Descripteurs français
- KwdFr :
- Adulte d'âge moyen, Complications postopératoires (), Conception de prothèse, Coronarographie, Endoprothèses, Femelle, Fonction ventriculaire gauche (physiologie), Humains, Implant résorbable, Infarctus du myocarde (), Infarctus du myocarde (diagnostic), Infarctus du myocarde (physiopathologie), Intervention coronarienne percutanée, Mâle, Méthode en double aveugle, Remodelage ventriculaire, Résultat thérapeutique, Sujet âgé, Vaisseaux coronaires (), Vaisseaux coronaires (imagerie diagnostique), Ventricules cardiaques (imagerie diagnostique), Ventricules cardiaques (physiopathologie), Électrocardiographie, Études de suivi.
- MESH :
- diagnostic : Infarctus du myocarde.
- imagerie diagnostique : Vaisseaux coronaires, Ventricules cardiaques.
- physiologie : Fonction ventriculaire gauche.
- physiopathologie : Infarctus du myocarde, Ventricules cardiaques.
- Adulte d'âge moyen, Complications postopératoires, Conception de prothèse, Coronarographie, Endoprothèses, Femelle, Humains, Implant résorbable, Infarctus du myocarde, Intervention coronarienne percutanée, Mâle, Méthode en double aveugle, Remodelage ventriculaire, Résultat thérapeutique, Sujet âgé, Vaisseaux coronaires, Électrocardiographie, Études de suivi.
English descriptors
- KwdEn :
- Absorbable Implants, Aged, Coronary Angiography, Coronary Vessels (diagnostic imaging), Coronary Vessels (surgery), Double-Blind Method, Electrocardiography, Female, Follow-Up Studies, Heart Ventricles (diagnostic imaging), Heart Ventricles (physiopathology), Humans, Male, Middle Aged, Myocardial Infarction (diagnosis), Myocardial Infarction (physiopathology), Myocardial Infarction (surgery), Percutaneous Coronary Intervention, Postoperative Complications (prevention & control), Prosthesis Design, Stents, Treatment Outcome, Ventricular Function, Left (physiology), Ventricular Remodeling.
- MESH :
- diagnosis : Myocardial Infarction.
- diagnostic imaging : Coronary Vessels, Heart Ventricles.
- physiology : Ventricular Function, Left.
- physiopathology : Heart Ventricles, Myocardial Infarction.
- prevention & control : Postoperative Complications.
- surgery : Coronary Vessels, Myocardial Infarction.
- Absorbable Implants, Aged, Coronary Angiography, Double-Blind Method, Electrocardiography, Female, Follow-Up Studies, Humans, Male, Middle Aged, Percutaneous Coronary Intervention, Prosthesis Design, Stents, Treatment Outcome, Ventricular Remodeling.
Abstract
Bioabsorbable cardiac matrix (BCM) is a novel device that attenuates adverse left ventricular (LV) remodeling after large myocardial infarctions in experimental models.
DOI: 10.1016/j.jacc.2016.05.053
PubMed: 27515331
Affiliations:
- Allemagne, Australie, Belgique, Canada, Espagne, France, Israël, Pologne, États-Unis
- Californie, Caroline du Nord, Communauté de Madrid, Massachusetts, Midi-Pyrénées, Minnesota, New Jersey, Occitanie (région administrative), Région de Bruxelles-Capitale, Schleswig-Holstein
- Bruxelles, Kiel, Madrid, Toulouse
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:27515331Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Bioabsorbable Intracoronary Matrix for Prevention of Ventricular Remodeling After Myocardial Infarction.</title>
<author><name sortKey="Rao, Sunil V" sort="Rao, Sunil V" uniqKey="Rao S" first="Sunil V" last="Rao">Sunil V. Rao</name>
<affiliation wicri:level="2"><nlm:affiliation>Duke Clinical Research Institute, Durham, North Carolina. Electronic address: sunil.rao@duke.edu.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Caroline du Nord</region>
</placeName>
<wicri:cityArea>Duke Clinical Research Institute, Durham</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Zeymer, Uwe" sort="Zeymer, Uwe" uniqKey="Zeymer U" first="Uwe" last="Zeymer">Uwe Zeymer</name>
<affiliation wicri:level="1"><nlm:affiliation>Herzzentrum Luwidshafen, Ludwigshafen, Germany.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Herzzentrum Luwidshafen, Ludwigshafen</wicri:regionArea>
<wicri:noRegion>Ludwigshafen</wicri:noRegion>
<wicri:noRegion>Ludwigshafen</wicri:noRegion>
<wicri:noRegion>Ludwigshafen</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Douglas, Pamela S" sort="Douglas, Pamela S" uniqKey="Douglas P" first="Pamela S" last="Douglas">Pamela S. Douglas</name>
<affiliation wicri:level="2"><nlm:affiliation>Duke Clinical Research Institute, Durham, North Carolina.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Caroline du Nord</region>
</placeName>
<wicri:cityArea>Duke Clinical Research Institute, Durham</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Al Khalidi, Hussein" sort="Al Khalidi, Hussein" uniqKey="Al Khalidi H" first="Hussein" last="Al-Khalidi">Hussein Al-Khalidi</name>
<affiliation wicri:level="2"><nlm:affiliation>Duke Clinical Research Institute, Durham, North Carolina.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Caroline du Nord</region>
</placeName>
<wicri:cityArea>Duke Clinical Research Institute, Durham</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="White, Jennifer A" sort="White, Jennifer A" uniqKey="White J" first="Jennifer A" last="White">Jennifer A. White</name>
<affiliation wicri:level="2"><nlm:affiliation>Duke Clinical Research Institute, Durham, North Carolina.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Caroline du Nord</region>
</placeName>
<wicri:cityArea>Duke Clinical Research Institute, Durham</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Liu, Jingyu" sort="Liu, Jingyu" uniqKey="Liu J" first="Jingyu" last="Liu">Jingyu Liu</name>
<affiliation wicri:level="2"><nlm:affiliation>Bellerophon Therapeutics Inc., Hampton, New Jersey.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">New Jersey</region>
</placeName>
<wicri:cityArea>Bellerophon Therapeutics Inc., Hampton</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Levy, Howard" sort="Levy, Howard" uniqKey="Levy H" first="Howard" last="Levy">Howard Levy</name>
<affiliation wicri:level="2"><nlm:affiliation>Bellerophon Therapeutics Inc., Hampton, New Jersey.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">New Jersey</region>
</placeName>
<wicri:cityArea>Bellerophon Therapeutics Inc., Hampton</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Guetta, Victor" sort="Guetta, Victor" uniqKey="Guetta V" first="Victor" last="Guetta">Victor Guetta</name>
<affiliation wicri:level="1"><nlm:affiliation>Sheba Tel Ha Shomer Hospital, Tel Ha Shomer, Israel.</nlm:affiliation>
<country xml:lang="fr">Israël</country>
<wicri:regionArea>Sheba Tel Ha Shomer Hospital, Tel Ha Shomer</wicri:regionArea>
<wicri:noRegion>Tel Ha Shomer</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Gibson, C Michael" sort="Gibson, C Michael" uniqKey="Gibson C" first="C Michael" last="Gibson">C Michael Gibson</name>
<affiliation wicri:level="2"><nlm:affiliation>Beth Israel Deaconess Medical Center, Boston, Massachusetts.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Massachusetts</region>
</placeName>
<wicri:cityArea>Beth Israel Deaconess Medical Center, Boston</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Tanguay, Jean Francois" sort="Tanguay, Jean Francois" uniqKey="Tanguay J" first="Jean-Francois" last="Tanguay">Jean-Francois Tanguay</name>
<affiliation wicri:level="1"><nlm:affiliation>Montreal Heart Institute, Montreal, Quebec, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Montreal Heart Institute, Montreal, Quebec</wicri:regionArea>
<wicri:noRegion>Quebec</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Vermeersch, Paul" sort="Vermeersch, Paul" uniqKey="Vermeersch P" first="Paul" last="Vermeersch">Paul Vermeersch</name>
<affiliation wicri:level="3"><nlm:affiliation>Free University, Brussels, Belgium.</nlm:affiliation>
<country xml:lang="fr">Belgique</country>
<wicri:regionArea>Free University, Brussels</wicri:regionArea>
<placeName><settlement type="city">Bruxelles</settlement>
<region nuts="2">Région de Bruxelles-Capitale</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Roncalli, Jerome" sort="Roncalli, Jerome" uniqKey="Roncalli J" first="Jérôme" last="Roncalli">Jérôme Roncalli</name>
<affiliation wicri:level="3"><nlm:affiliation>Rangueil University Hospital, Toulouse, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Rangueil University Hospital, Toulouse</wicri:regionArea>
<placeName><region type="region">Occitanie (région administrative)</region>
<region type="old region">Midi-Pyrénées</region>
<settlement type="city">Toulouse</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Kasprzak, Jaroslaw D" sort="Kasprzak, Jaroslaw D" uniqKey="Kasprzak J" first="Jaroslaw D" last="Kasprzak">Jaroslaw D. Kasprzak</name>
<affiliation wicri:level="1"><nlm:affiliation>Medical University of Lodz, Lodz, Poland.</nlm:affiliation>
<country xml:lang="fr">Pologne</country>
<wicri:regionArea>Medical University of Lodz, Lodz</wicri:regionArea>
<wicri:noRegion>Lodz</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Henry, Timothy D" sort="Henry, Timothy D" uniqKey="Henry T" first="Timothy D" last="Henry">Timothy D. Henry</name>
<affiliation wicri:level="2"><nlm:affiliation>Cedars-Sinai Heart Institute, Los Angeles, California.</nlm:affiliation>
<country>États-Unis</country>
<placeName><region type="state">Californie</region>
</placeName>
<wicri:cityArea>Cedars-Sinai Heart Institute, Los Angeles</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Frey, Norbert" sort="Frey, Norbert" uniqKey="Frey N" first="Norbert" last="Frey">Norbert Frey</name>
<affiliation wicri:level="3"><nlm:affiliation>Universitätsklinikum Schleswig-Holstein, Campus Kiel Klinik für Kardiologie und Angiologie, Kiel, Germany.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Universitätsklinikum Schleswig-Holstein, Campus Kiel Klinik für Kardiologie und Angiologie, Kiel</wicri:regionArea>
<placeName><region type="land" nuts="2">Schleswig-Holstein</region>
<settlement type="city">Kiel</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Kracoff, Oscar" sort="Kracoff, Oscar" uniqKey="Kracoff O" first="Oscar" last="Kracoff">Oscar Kracoff</name>
<affiliation wicri:level="1"><nlm:affiliation>Kaplan Medical Center, Rehovot, Israel.</nlm:affiliation>
<country xml:lang="fr">Israël</country>
<wicri:regionArea>Kaplan Medical Center, Rehovot</wicri:regionArea>
<wicri:noRegion>Rehovot</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Traverse, Jay H" sort="Traverse, Jay H" uniqKey="Traverse J" first="Jay H" last="Traverse">Jay H. Traverse</name>
<affiliation wicri:level="2"><nlm:affiliation>Minneapolis Heart Institute, Minneapolis, Minnesota.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Minnesota</region>
</placeName>
<wicri:cityArea>Minneapolis Heart Institute, Minneapolis</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Chew, Derek P" sort="Chew, Derek P" uniqKey="Chew D" first="Derek P" last="Chew">Derek P. Chew</name>
<affiliation wicri:level="1"><nlm:affiliation>Flinders University, Adelaide, South Australia, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Flinders University, Adelaide, South Australia</wicri:regionArea>
<wicri:noRegion>South Australia</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Lopez Sendon, Jose" sort="Lopez Sendon, Jose" uniqKey="Lopez Sendon J" first="Jose" last="Lopez-Sendon">Jose Lopez-Sendon</name>
<affiliation wicri:level="3"><nlm:affiliation>Hospital Universitario La Paz, Madrid, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Hospital Universitario La Paz, Madrid</wicri:regionArea>
<placeName><settlement type="city">Madrid</settlement>
<region nuts="2" type="region">Communauté de Madrid</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Heyrman, Reinilde" sort="Heyrman, Reinilde" uniqKey="Heyrman R" first="Reinilde" last="Heyrman">Reinilde Heyrman</name>
<affiliation wicri:level="2"><nlm:affiliation>Bellerophon Therapeutics Inc., Hampton, New Jersey.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">New Jersey</region>
</placeName>
<wicri:cityArea>Bellerophon Therapeutics Inc., Hampton</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Krucoff, Mitchell W" sort="Krucoff, Mitchell W" uniqKey="Krucoff M" first="Mitchell W" last="Krucoff">Mitchell W. Krucoff</name>
<affiliation wicri:level="2"><nlm:affiliation>Duke Clinical Research Institute, Durham, North Carolina.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Caroline du Nord</region>
</placeName>
<wicri:cityArea>Duke Clinical Research Institute, Durham</wicri:cityArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2016">2016</date>
<idno type="RBID">pubmed:27515331</idno>
<idno type="pmid">27515331</idno>
<idno type="doi">10.1016/j.jacc.2016.05.053</idno>
<idno type="wicri:Area/PubMed/Corpus">001A99</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001A99</idno>
<idno type="wicri:Area/PubMed/Curation">001A75</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001A75</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001A75</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001A75</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Bioabsorbable Intracoronary Matrix for Prevention of Ventricular Remodeling After Myocardial Infarction.</title>
<author><name sortKey="Rao, Sunil V" sort="Rao, Sunil V" uniqKey="Rao S" first="Sunil V" last="Rao">Sunil V. Rao</name>
<affiliation wicri:level="2"><nlm:affiliation>Duke Clinical Research Institute, Durham, North Carolina. Electronic address: sunil.rao@duke.edu.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Caroline du Nord</region>
</placeName>
<wicri:cityArea>Duke Clinical Research Institute, Durham</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Zeymer, Uwe" sort="Zeymer, Uwe" uniqKey="Zeymer U" first="Uwe" last="Zeymer">Uwe Zeymer</name>
<affiliation wicri:level="1"><nlm:affiliation>Herzzentrum Luwidshafen, Ludwigshafen, Germany.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Herzzentrum Luwidshafen, Ludwigshafen</wicri:regionArea>
<wicri:noRegion>Ludwigshafen</wicri:noRegion>
<wicri:noRegion>Ludwigshafen</wicri:noRegion>
<wicri:noRegion>Ludwigshafen</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Douglas, Pamela S" sort="Douglas, Pamela S" uniqKey="Douglas P" first="Pamela S" last="Douglas">Pamela S. Douglas</name>
<affiliation wicri:level="2"><nlm:affiliation>Duke Clinical Research Institute, Durham, North Carolina.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Caroline du Nord</region>
</placeName>
<wicri:cityArea>Duke Clinical Research Institute, Durham</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Al Khalidi, Hussein" sort="Al Khalidi, Hussein" uniqKey="Al Khalidi H" first="Hussein" last="Al-Khalidi">Hussein Al-Khalidi</name>
<affiliation wicri:level="2"><nlm:affiliation>Duke Clinical Research Institute, Durham, North Carolina.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Caroline du Nord</region>
</placeName>
<wicri:cityArea>Duke Clinical Research Institute, Durham</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="White, Jennifer A" sort="White, Jennifer A" uniqKey="White J" first="Jennifer A" last="White">Jennifer A. White</name>
<affiliation wicri:level="2"><nlm:affiliation>Duke Clinical Research Institute, Durham, North Carolina.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Caroline du Nord</region>
</placeName>
<wicri:cityArea>Duke Clinical Research Institute, Durham</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Liu, Jingyu" sort="Liu, Jingyu" uniqKey="Liu J" first="Jingyu" last="Liu">Jingyu Liu</name>
<affiliation wicri:level="2"><nlm:affiliation>Bellerophon Therapeutics Inc., Hampton, New Jersey.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">New Jersey</region>
</placeName>
<wicri:cityArea>Bellerophon Therapeutics Inc., Hampton</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Levy, Howard" sort="Levy, Howard" uniqKey="Levy H" first="Howard" last="Levy">Howard Levy</name>
<affiliation wicri:level="2"><nlm:affiliation>Bellerophon Therapeutics Inc., Hampton, New Jersey.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">New Jersey</region>
</placeName>
<wicri:cityArea>Bellerophon Therapeutics Inc., Hampton</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Guetta, Victor" sort="Guetta, Victor" uniqKey="Guetta V" first="Victor" last="Guetta">Victor Guetta</name>
<affiliation wicri:level="1"><nlm:affiliation>Sheba Tel Ha Shomer Hospital, Tel Ha Shomer, Israel.</nlm:affiliation>
<country xml:lang="fr">Israël</country>
<wicri:regionArea>Sheba Tel Ha Shomer Hospital, Tel Ha Shomer</wicri:regionArea>
<wicri:noRegion>Tel Ha Shomer</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Gibson, C Michael" sort="Gibson, C Michael" uniqKey="Gibson C" first="C Michael" last="Gibson">C Michael Gibson</name>
<affiliation wicri:level="2"><nlm:affiliation>Beth Israel Deaconess Medical Center, Boston, Massachusetts.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Massachusetts</region>
</placeName>
<wicri:cityArea>Beth Israel Deaconess Medical Center, Boston</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Tanguay, Jean Francois" sort="Tanguay, Jean Francois" uniqKey="Tanguay J" first="Jean-Francois" last="Tanguay">Jean-Francois Tanguay</name>
<affiliation wicri:level="1"><nlm:affiliation>Montreal Heart Institute, Montreal, Quebec, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Montreal Heart Institute, Montreal, Quebec</wicri:regionArea>
<wicri:noRegion>Quebec</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Vermeersch, Paul" sort="Vermeersch, Paul" uniqKey="Vermeersch P" first="Paul" last="Vermeersch">Paul Vermeersch</name>
<affiliation wicri:level="3"><nlm:affiliation>Free University, Brussels, Belgium.</nlm:affiliation>
<country xml:lang="fr">Belgique</country>
<wicri:regionArea>Free University, Brussels</wicri:regionArea>
<placeName><settlement type="city">Bruxelles</settlement>
<region nuts="2">Région de Bruxelles-Capitale</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Roncalli, Jerome" sort="Roncalli, Jerome" uniqKey="Roncalli J" first="Jérôme" last="Roncalli">Jérôme Roncalli</name>
<affiliation wicri:level="3"><nlm:affiliation>Rangueil University Hospital, Toulouse, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Rangueil University Hospital, Toulouse</wicri:regionArea>
<placeName><region type="region">Occitanie (région administrative)</region>
<region type="old region">Midi-Pyrénées</region>
<settlement type="city">Toulouse</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Kasprzak, Jaroslaw D" sort="Kasprzak, Jaroslaw D" uniqKey="Kasprzak J" first="Jaroslaw D" last="Kasprzak">Jaroslaw D. Kasprzak</name>
<affiliation wicri:level="1"><nlm:affiliation>Medical University of Lodz, Lodz, Poland.</nlm:affiliation>
<country xml:lang="fr">Pologne</country>
<wicri:regionArea>Medical University of Lodz, Lodz</wicri:regionArea>
<wicri:noRegion>Lodz</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Henry, Timothy D" sort="Henry, Timothy D" uniqKey="Henry T" first="Timothy D" last="Henry">Timothy D. Henry</name>
<affiliation wicri:level="2"><nlm:affiliation>Cedars-Sinai Heart Institute, Los Angeles, California.</nlm:affiliation>
<country>États-Unis</country>
<placeName><region type="state">Californie</region>
</placeName>
<wicri:cityArea>Cedars-Sinai Heart Institute, Los Angeles</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Frey, Norbert" sort="Frey, Norbert" uniqKey="Frey N" first="Norbert" last="Frey">Norbert Frey</name>
<affiliation wicri:level="3"><nlm:affiliation>Universitätsklinikum Schleswig-Holstein, Campus Kiel Klinik für Kardiologie und Angiologie, Kiel, Germany.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Universitätsklinikum Schleswig-Holstein, Campus Kiel Klinik für Kardiologie und Angiologie, Kiel</wicri:regionArea>
<placeName><region type="land" nuts="2">Schleswig-Holstein</region>
<settlement type="city">Kiel</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Kracoff, Oscar" sort="Kracoff, Oscar" uniqKey="Kracoff O" first="Oscar" last="Kracoff">Oscar Kracoff</name>
<affiliation wicri:level="1"><nlm:affiliation>Kaplan Medical Center, Rehovot, Israel.</nlm:affiliation>
<country xml:lang="fr">Israël</country>
<wicri:regionArea>Kaplan Medical Center, Rehovot</wicri:regionArea>
<wicri:noRegion>Rehovot</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Traverse, Jay H" sort="Traverse, Jay H" uniqKey="Traverse J" first="Jay H" last="Traverse">Jay H. Traverse</name>
<affiliation wicri:level="2"><nlm:affiliation>Minneapolis Heart Institute, Minneapolis, Minnesota.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Minnesota</region>
</placeName>
<wicri:cityArea>Minneapolis Heart Institute, Minneapolis</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Chew, Derek P" sort="Chew, Derek P" uniqKey="Chew D" first="Derek P" last="Chew">Derek P. Chew</name>
<affiliation wicri:level="1"><nlm:affiliation>Flinders University, Adelaide, South Australia, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Flinders University, Adelaide, South Australia</wicri:regionArea>
<wicri:noRegion>South Australia</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Lopez Sendon, Jose" sort="Lopez Sendon, Jose" uniqKey="Lopez Sendon J" first="Jose" last="Lopez-Sendon">Jose Lopez-Sendon</name>
<affiliation wicri:level="3"><nlm:affiliation>Hospital Universitario La Paz, Madrid, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Hospital Universitario La Paz, Madrid</wicri:regionArea>
<placeName><settlement type="city">Madrid</settlement>
<region nuts="2" type="region">Communauté de Madrid</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Heyrman, Reinilde" sort="Heyrman, Reinilde" uniqKey="Heyrman R" first="Reinilde" last="Heyrman">Reinilde Heyrman</name>
<affiliation wicri:level="2"><nlm:affiliation>Bellerophon Therapeutics Inc., Hampton, New Jersey.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">New Jersey</region>
</placeName>
<wicri:cityArea>Bellerophon Therapeutics Inc., Hampton</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Krucoff, Mitchell W" sort="Krucoff, Mitchell W" uniqKey="Krucoff M" first="Mitchell W" last="Krucoff">Mitchell W. Krucoff</name>
<affiliation wicri:level="2"><nlm:affiliation>Duke Clinical Research Institute, Durham, North Carolina.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Caroline du Nord</region>
</placeName>
<wicri:cityArea>Duke Clinical Research Institute, Durham</wicri:cityArea>
</affiliation>
</author>
</analytic>
<series><title level="j">Journal of the American College of Cardiology</title>
<idno type="eISSN">1558-3597</idno>
<imprint><date when="2016" type="published">2016</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Absorbable Implants</term>
<term>Aged</term>
<term>Coronary Angiography</term>
<term>Coronary Vessels (diagnostic imaging)</term>
<term>Coronary Vessels (surgery)</term>
<term>Double-Blind Method</term>
<term>Electrocardiography</term>
<term>Female</term>
<term>Follow-Up Studies</term>
<term>Heart Ventricles (diagnostic imaging)</term>
<term>Heart Ventricles (physiopathology)</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Myocardial Infarction (diagnosis)</term>
<term>Myocardial Infarction (physiopathology)</term>
<term>Myocardial Infarction (surgery)</term>
<term>Percutaneous Coronary Intervention</term>
<term>Postoperative Complications (prevention & control)</term>
<term>Prosthesis Design</term>
<term>Stents</term>
<term>Treatment Outcome</term>
<term>Ventricular Function, Left (physiology)</term>
<term>Ventricular Remodeling</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Adulte d'âge moyen</term>
<term>Complications postopératoires ()</term>
<term>Conception de prothèse</term>
<term>Coronarographie</term>
<term>Endoprothèses</term>
<term>Femelle</term>
<term>Fonction ventriculaire gauche (physiologie)</term>
<term>Humains</term>
<term>Implant résorbable</term>
<term>Infarctus du myocarde ()</term>
<term>Infarctus du myocarde (diagnostic)</term>
<term>Infarctus du myocarde (physiopathologie)</term>
<term>Intervention coronarienne percutanée</term>
<term>Mâle</term>
<term>Méthode en double aveugle</term>
<term>Remodelage ventriculaire</term>
<term>Résultat thérapeutique</term>
<term>Sujet âgé</term>
<term>Vaisseaux coronaires ()</term>
<term>Vaisseaux coronaires (imagerie diagnostique)</term>
<term>Ventricules cardiaques (imagerie diagnostique)</term>
<term>Ventricules cardiaques (physiopathologie)</term>
<term>Électrocardiographie</term>
<term>Études de suivi</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Myocardial Infarction</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Infarctus du myocarde</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnostic imaging" xml:lang="en"><term>Coronary Vessels</term>
<term>Heart Ventricles</term>
</keywords>
<keywords scheme="MESH" qualifier="imagerie diagnostique" xml:lang="fr"><term>Vaisseaux coronaires</term>
<term>Ventricules cardiaques</term>
</keywords>
<keywords scheme="MESH" qualifier="physiologie" xml:lang="fr"><term>Fonction ventriculaire gauche</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en"><term>Ventricular Function, Left</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathologie" xml:lang="fr"><term>Infarctus du myocarde</term>
<term>Ventricules cardiaques</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Heart Ventricles</term>
<term>Myocardial Infarction</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Postoperative Complications</term>
</keywords>
<keywords scheme="MESH" qualifier="surgery" xml:lang="en"><term>Coronary Vessels</term>
<term>Myocardial Infarction</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Absorbable Implants</term>
<term>Aged</term>
<term>Coronary Angiography</term>
<term>Double-Blind Method</term>
<term>Electrocardiography</term>
<term>Female</term>
<term>Follow-Up Studies</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Percutaneous Coronary Intervention</term>
<term>Prosthesis Design</term>
<term>Stents</term>
<term>Treatment Outcome</term>
<term>Ventricular Remodeling</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adulte d'âge moyen</term>
<term>Complications postopératoires</term>
<term>Conception de prothèse</term>
<term>Coronarographie</term>
<term>Endoprothèses</term>
<term>Femelle</term>
<term>Humains</term>
<term>Implant résorbable</term>
<term>Infarctus du myocarde</term>
<term>Intervention coronarienne percutanée</term>
<term>Mâle</term>
<term>Méthode en double aveugle</term>
<term>Remodelage ventriculaire</term>
<term>Résultat thérapeutique</term>
<term>Sujet âgé</term>
<term>Vaisseaux coronaires</term>
<term>Électrocardiographie</term>
<term>Études de suivi</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Bioabsorbable cardiac matrix (BCM) is a novel device that attenuates adverse left ventricular (LV) remodeling after large myocardial infarctions in experimental models.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">27515331</PMID>
<DateCreated><Year>2016</Year>
<Month>08</Month>
<Day>12</Day>
</DateCreated>
<DateCompleted><Year>2017</Year>
<Month>06</Month>
<Day>30</Day>
</DateCompleted>
<DateRevised><Year>2017</Year>
<Month>06</Month>
<Day>30</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1558-3597</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>68</Volume>
<Issue>7</Issue>
<PubDate><Year>2016</Year>
<Month>Aug</Month>
<Day>16</Day>
</PubDate>
</JournalIssue>
<Title>Journal of the American College of Cardiology</Title>
<ISOAbbreviation>J. Am. Coll. Cardiol.</ISOAbbreviation>
</Journal>
<ArticleTitle>Bioabsorbable Intracoronary Matrix for Prevention of Ventricular Remodeling After Myocardial Infarction.</ArticleTitle>
<Pagination><MedlinePgn>715-23</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jacc.2016.05.053</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0735-1097(16)33391-5</ELocationID>
<Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Bioabsorbable cardiac matrix (BCM) is a novel device that attenuates adverse left ventricular (LV) remodeling after large myocardial infarctions in experimental models.</AbstractText>
<AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">This study aimed to analyze whether BCM, compared with saline control, would result in less LV dilation and fewer adverse clinical events between baseline and 6 months.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">In an international, randomized, double-blind, controlled trial, 303 subjects with large areas of infarction despite successful primary percutaneous coronary intervention (PCI) of ST-segment elevation myocardial infarction (STEMI) were randomized 2:1 to BCM or saline injected into the infarct-related artery 2 to 5 days after primary PCI. The primary outcome was mean change from baseline in LV end-diastolic volume index (LVEDVI) at 6 months. Secondary outcomes included change in Kansas City Cardiomyopathy Questionnaire score, 6-minute walk time, and New York Heart Association functional class at 6 months. The primary safety endpoint was a composite of cardiovascular death, recurrent MI, target-vessel revascularization, stent thrombosis, significant arrhythmia requiring therapy, or myocardial rupture through 6 months.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">In total, 201 subjects were assigned to BCM and 102 to saline control. There was no significant difference in change in LVEDVI from baseline to 6 months between the groups (mean change ± SD: BCM 14.1 ± 28.9 ml/m(2) vs. saline 11.7 ± 26.9 ml/m(2); p = 0.49). There was also no significant difference in the secondary endpoints. The rates of the primary safety outcome were similar between the 2 groups (BCM 11.6% vs. saline 9.1%; p = 0.37).</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Intracoronary deployment of BCM 2 to 5 days after successful reperfusion in subjects with large myocardial infarction did not reduce adverse LV remodeling or cardiac clinical events at 6 months. (IK-5001 for the Prevention of Remodeling of the Ventricle and Congestive Heart Failure After Acute Myocardial Infarction [PRESERVATION I]; NCT01226563).</AbstractText>
<CopyrightInformation>Copyright © 2016 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rao</LastName>
<ForeName>Sunil V</ForeName>
<Initials>SV</Initials>
<AffiliationInfo><Affiliation>Duke Clinical Research Institute, Durham, North Carolina. Electronic address: sunil.rao@duke.edu.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Zeymer</LastName>
<ForeName>Uwe</ForeName>
<Initials>U</Initials>
<AffiliationInfo><Affiliation>Herzzentrum Luwidshafen, Ludwigshafen, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Douglas</LastName>
<ForeName>Pamela S</ForeName>
<Initials>PS</Initials>
<AffiliationInfo><Affiliation>Duke Clinical Research Institute, Durham, North Carolina.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Al-Khalidi</LastName>
<ForeName>Hussein</ForeName>
<Initials>H</Initials>
<AffiliationInfo><Affiliation>Duke Clinical Research Institute, Durham, North Carolina.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>White</LastName>
<ForeName>Jennifer A</ForeName>
<Initials>JA</Initials>
<AffiliationInfo><Affiliation>Duke Clinical Research Institute, Durham, North Carolina.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Liu</LastName>
<ForeName>Jingyu</ForeName>
<Initials>J</Initials>
<AffiliationInfo><Affiliation>Bellerophon Therapeutics Inc., Hampton, New Jersey.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Levy</LastName>
<ForeName>Howard</ForeName>
<Initials>H</Initials>
<AffiliationInfo><Affiliation>Bellerophon Therapeutics Inc., Hampton, New Jersey.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Guetta</LastName>
<ForeName>Victor</ForeName>
<Initials>V</Initials>
<AffiliationInfo><Affiliation>Sheba Tel Ha Shomer Hospital, Tel Ha Shomer, Israel.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Gibson</LastName>
<ForeName>C Michael</ForeName>
<Initials>CM</Initials>
<AffiliationInfo><Affiliation>Beth Israel Deaconess Medical Center, Boston, Massachusetts.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Tanguay</LastName>
<ForeName>Jean-Francois</ForeName>
<Initials>JF</Initials>
<AffiliationInfo><Affiliation>Montreal Heart Institute, Montreal, Quebec, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Vermeersch</LastName>
<ForeName>Paul</ForeName>
<Initials>P</Initials>
<AffiliationInfo><Affiliation>Free University, Brussels, Belgium.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Roncalli</LastName>
<ForeName>Jérôme</ForeName>
<Initials>J</Initials>
<AffiliationInfo><Affiliation>Rangueil University Hospital, Toulouse, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Kasprzak</LastName>
<ForeName>Jaroslaw D</ForeName>
<Initials>JD</Initials>
<AffiliationInfo><Affiliation>Medical University of Lodz, Lodz, Poland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Henry</LastName>
<ForeName>Timothy D</ForeName>
<Initials>TD</Initials>
<AffiliationInfo><Affiliation>Cedars-Sinai Heart Institute, Los Angeles, California.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Frey</LastName>
<ForeName>Norbert</ForeName>
<Initials>N</Initials>
<AffiliationInfo><Affiliation>Universitätsklinikum Schleswig-Holstein, Campus Kiel Klinik für Kardiologie und Angiologie, Kiel, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Kracoff</LastName>
<ForeName>Oscar</ForeName>
<Initials>O</Initials>
<AffiliationInfo><Affiliation>Kaplan Medical Center, Rehovot, Israel.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Traverse</LastName>
<ForeName>Jay H</ForeName>
<Initials>JH</Initials>
<AffiliationInfo><Affiliation>Minneapolis Heart Institute, Minneapolis, Minnesota.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Chew</LastName>
<ForeName>Derek P</ForeName>
<Initials>DP</Initials>
<AffiliationInfo><Affiliation>Flinders University, Adelaide, South Australia, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Lopez-Sendon</LastName>
<ForeName>Jose</ForeName>
<Initials>J</Initials>
<AffiliationInfo><Affiliation>Hospital Universitario La Paz, Madrid, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Heyrman</LastName>
<ForeName>Reinilde</ForeName>
<Initials>R</Initials>
<AffiliationInfo><Affiliation>Bellerophon Therapeutics Inc., Hampton, New Jersey.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Krucoff</LastName>
<ForeName>Mitchell W</ForeName>
<Initials>MW</Initials>
<AffiliationInfo><Affiliation>Duke Clinical Research Institute, Durham, North Carolina.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName>
<AccessionNumberList><AccessionNumber>NCT01226563</AccessionNumber>
</AccessionNumberList>
</DataBank>
</DataBankList>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016448">Multicenter Study</PublicationType>
<PublicationType UI="D016449">Randomized Controlled Trial</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>J Am Coll Cardiol</MedlineTA>
<NlmUniqueID>8301365</NlmUniqueID>
<ISSNLinking>0735-1097</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D020341" MajorTopicYN="Y">Absorbable Implants</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D017023" MajorTopicYN="N">Coronary Angiography</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003331" MajorTopicYN="N">Coronary Vessels</DescriptorName>
<QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName>
<QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004311" MajorTopicYN="N">Double-Blind Method</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004562" MajorTopicYN="N">Electrocardiography</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006352" MajorTopicYN="N">Heart Ventricles</DescriptorName>
<QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName>
<QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D009203" MajorTopicYN="N">Myocardial Infarction</DescriptorName>
<QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
<QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
<QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D062645" MajorTopicYN="Y">Percutaneous Coronary Intervention</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName>
<QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011474" MajorTopicYN="N">Prosthesis Design</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015607" MajorTopicYN="Y">Stents</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016277" MajorTopicYN="N">Ventricular Function, Left</DescriptorName>
<QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D020257" MajorTopicYN="Y">Ventricular Remodeling</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">alginate</Keyword>
<Keyword MajorTopicYN="N">congestive heart failure</Keyword>
<Keyword MajorTopicYN="N">deployment</Keyword>
<Keyword MajorTopicYN="N">echocardiography</Keyword>
<Keyword MajorTopicYN="N">end-diastolic volume</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year>
<Month>04</Month>
<Day>07</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2016</Year>
<Month>05</Month>
<Day>10</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2016</Year>
<Month>8</Month>
<Day>13</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2016</Year>
<Month>8</Month>
<Day>16</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2017</Year>
<Month>7</Month>
<Day>1</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">27515331</ArticleId>
<ArticleId IdType="pii">S0735-1097(16)33391-5</ArticleId>
<ArticleId IdType="doi">10.1016/j.jacc.2016.05.053</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Allemagne</li>
<li>Australie</li>
<li>Belgique</li>
<li>Canada</li>
<li>Espagne</li>
<li>France</li>
<li>Israël</li>
<li>Pologne</li>
<li>États-Unis</li>
</country>
<region><li>Californie</li>
<li>Caroline du Nord</li>
<li>Communauté de Madrid</li>
<li>Massachusetts</li>
<li>Midi-Pyrénées</li>
<li>Minnesota</li>
<li>New Jersey</li>
<li>Occitanie (région administrative)</li>
<li>Région de Bruxelles-Capitale</li>
<li>Schleswig-Holstein</li>
</region>
<settlement><li>Bruxelles</li>
<li>Kiel</li>
<li>Madrid</li>
<li>Toulouse</li>
</settlement>
</list>
<tree><country name="États-Unis"><region name="Caroline du Nord"><name sortKey="Rao, Sunil V" sort="Rao, Sunil V" uniqKey="Rao S" first="Sunil V" last="Rao">Sunil V. Rao</name>
</region>
<name sortKey="Al Khalidi, Hussein" sort="Al Khalidi, Hussein" uniqKey="Al Khalidi H" first="Hussein" last="Al-Khalidi">Hussein Al-Khalidi</name>
<name sortKey="Douglas, Pamela S" sort="Douglas, Pamela S" uniqKey="Douglas P" first="Pamela S" last="Douglas">Pamela S. Douglas</name>
<name sortKey="Gibson, C Michael" sort="Gibson, C Michael" uniqKey="Gibson C" first="C Michael" last="Gibson">C Michael Gibson</name>
<name sortKey="Henry, Timothy D" sort="Henry, Timothy D" uniqKey="Henry T" first="Timothy D" last="Henry">Timothy D. Henry</name>
<name sortKey="Heyrman, Reinilde" sort="Heyrman, Reinilde" uniqKey="Heyrman R" first="Reinilde" last="Heyrman">Reinilde Heyrman</name>
<name sortKey="Krucoff, Mitchell W" sort="Krucoff, Mitchell W" uniqKey="Krucoff M" first="Mitchell W" last="Krucoff">Mitchell W. Krucoff</name>
<name sortKey="Levy, Howard" sort="Levy, Howard" uniqKey="Levy H" first="Howard" last="Levy">Howard Levy</name>
<name sortKey="Liu, Jingyu" sort="Liu, Jingyu" uniqKey="Liu J" first="Jingyu" last="Liu">Jingyu Liu</name>
<name sortKey="Traverse, Jay H" sort="Traverse, Jay H" uniqKey="Traverse J" first="Jay H" last="Traverse">Jay H. Traverse</name>
<name sortKey="White, Jennifer A" sort="White, Jennifer A" uniqKey="White J" first="Jennifer A" last="White">Jennifer A. White</name>
</country>
<country name="Allemagne"><noRegion><name sortKey="Zeymer, Uwe" sort="Zeymer, Uwe" uniqKey="Zeymer U" first="Uwe" last="Zeymer">Uwe Zeymer</name>
</noRegion>
<name sortKey="Frey, Norbert" sort="Frey, Norbert" uniqKey="Frey N" first="Norbert" last="Frey">Norbert Frey</name>
</country>
<country name="Israël"><noRegion><name sortKey="Guetta, Victor" sort="Guetta, Victor" uniqKey="Guetta V" first="Victor" last="Guetta">Victor Guetta</name>
</noRegion>
<name sortKey="Kracoff, Oscar" sort="Kracoff, Oscar" uniqKey="Kracoff O" first="Oscar" last="Kracoff">Oscar Kracoff</name>
</country>
<country name="Canada"><noRegion><name sortKey="Tanguay, Jean Francois" sort="Tanguay, Jean Francois" uniqKey="Tanguay J" first="Jean-Francois" last="Tanguay">Jean-Francois Tanguay</name>
</noRegion>
</country>
<country name="Belgique"><region name="Région de Bruxelles-Capitale"><name sortKey="Vermeersch, Paul" sort="Vermeersch, Paul" uniqKey="Vermeersch P" first="Paul" last="Vermeersch">Paul Vermeersch</name>
</region>
</country>
<country name="France"><region name="Occitanie (région administrative)"><name sortKey="Roncalli, Jerome" sort="Roncalli, Jerome" uniqKey="Roncalli J" first="Jérôme" last="Roncalli">Jérôme Roncalli</name>
</region>
</country>
<country name="Pologne"><noRegion><name sortKey="Kasprzak, Jaroslaw D" sort="Kasprzak, Jaroslaw D" uniqKey="Kasprzak J" first="Jaroslaw D" last="Kasprzak">Jaroslaw D. Kasprzak</name>
</noRegion>
</country>
<country name="Australie"><noRegion><name sortKey="Chew, Derek P" sort="Chew, Derek P" uniqKey="Chew D" first="Derek P" last="Chew">Derek P. Chew</name>
</noRegion>
</country>
<country name="Espagne"><region name="Communauté de Madrid"><name sortKey="Lopez Sendon, Jose" sort="Lopez Sendon, Jose" uniqKey="Lopez Sendon J" first="Jose" last="Lopez-Sendon">Jose Lopez-Sendon</name>
</region>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002263 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 002263 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Asie |area= AustralieFrV1 |flux= PubMed |étape= Checkpoint |type= RBID |clé= pubmed:27515331 |texte= Bioabsorbable Intracoronary Matrix for Prevention of Ventricular Remodeling After Myocardial Infarction. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:27515331" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \ | NlmPubMed2Wicri -a AustralieFrV1
This area was generated with Dilib version V0.6.33. |